Umbukiso we-Guangzhou API ngo-2021

gae

awu 86th I-China International Pharmaceutical Raw Materials/I-Intermediates/Packaging/Equipment Fair (i-API yase-China kafushane)

Umhleli: Reed Sinopharm Exhibition Co., Ltd.

Isikhathi sombukiso: Meyi 26-28, 2021

Indawo: I-China Import and Export Fair Complex (Guangzhou)

Isikali sombukiso: 60,000 square metres

Ababonisi: 1500+

Inombolo yezithameli: 60000+

Thina,I-Changzhou Pharmaceutiacl Factoryokuphethwe yi-Shanghai Pharma.,izoba khonaI-China Import and Export Fair Complex (i-Guangzhou)ngo 10.2M15 ngoba ti-86th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (i-API China ngamafuphi)

Eminyakeni yakamuva, izwe lami likhiphe uchungechunge lwezinqubomgomo ngokulandelana ukuze likhuthaze futhi lisekele ukuthuthukiswa kwemboni yezokwelashwa.Kulo mongo, imboni ye-biopharmaceutical nayo isiqalile ukungena esigabeni sokuthuthuka ngokushesha, futhi ibonise ukukhula okunamandla okukhulayo.Njengamanje, izinga layo lokukhula kwemakethe seliqale ukudlula kancane kancane isimo semakethe yemithi.Ngokombiko we-Frost & Sullivan, ngo-2019, imakethe ye-biopharmaceutical yaseChina yafinyelela kuma-yuan ayizigidi eziyizinkulungwane ezingama-317.2.Ngokukhula kokukwazi ukuthengeka, ukukhula kwesibalo seziguli kanye nokwanda komshwalense wezokwelapha, imakethe ye-biopharmaceutical kulindeleke ukuthi ifinyelele kuma-yuan ayizigidi eziyizinkulungwane ezingama-464.4 ngo-2021.

Ngemuva kwalokho, lapho sibhekene namathemba amakhulu emakethe, yimiphi imigqa eyinhloko yokutshala imali embonini ye-biopharmaceutical efanele ukunakwa ngo-2021?Ngokusho kwemboni, ngokusekelwe ekudonseleni emuva kwemboni yezemithi, kunconywa ukuthi unake imigqa emithathu eyinhloko yokutshala imali ngaphansi komkhuba ojwayelekile wokuthuthukiswa kwezimboni.:

一.Amabhizinisi asungulayo ekhwalithi ephezulu anokuncintisana komhlaba

Imithi ibilokhu iyimboni yokuphuma kwelanga enentuthuko eqinile.Kodwa-ke, ngaphansi kwesizinda sokuthi imboni yemithi ingena ekuthuthukisweni kwekhwalithi ephezulu futhi imboni isheshisa ukuguqulwa kwayo, ukuthuthukiswa kwemithi emisha yizinkampani ezithaka imithi kuyisihluthulelo sokuxazulula izidingo zomtholampilo ezingafinyeleli, ukusekela kanye nokuncintisana. 

Njengamanje, ngokombono wembulunga yonke, izinkampani ezinkulu ezinkulu zemithi zonke ziyizinkampani zemithi ezisungula izinto ezintsha.Isibonelo, inani lemakethe likaJohnson & Johnson, elinomuthi kanye nemishini, liphezulu njengoba lifinyelela ku-374.5 wamadola aseMelika, futhi inani lemakethe lezinkampani zemithi eziphezulu ezifana ne-Roche ne-Pfizer nazo zingaphezu kwezigidigidi eziyi-100 zamadola aseMelika;kodwa njengoba i-Teva Pharmaceuticals, enye yezinkampani ezinkulu zemithi ejwayelekile emhlabeni, inenani lemakethe lamabhiliyoni ayi-12.3 kuphela.Kuyabonakala kulokhu okungenhla ukuthi ukuqamba okusha sekunamandla okuqhuba ukuthuthukiswa okungcono kwemboni ye-biomedical kanye namabhizinisi.

Kuyaphawuleka ukuthi uma sifuna ukuba nezimakethe eziningi, akwanele ukuthembela emakethe yasekhaya kuphela.Kuphela ngokuphusha izidakamizwa eziqhudelana namazwe ngamazwe phesheya kwezilwandle nokubamba iqhaza emqhudelwaneni wemakethe yomhlaba ngesikhala esiningi singakwazi ukuba nethuba lokuthola imbuyiselo engcono..Ngakho-ke, imboni ngokuvamile ikholelwa ukuthi izinkampani ezintsha ezisezingeni eliphezulu ezinokuncintisana komhlaba wonke zinamathuba amaningi okuthuthuka.Kunconywa ukuthi unake izinkampani ezithaka imithi ezisungule iziteshi zokuthengisa eziqondile phesheya kwezilwandle.

二.Umkhakha wabahlomuli ohlobene nama-DRGs

Ngo-2021, ukukhokha kwangempela kwama-DRG kuzoqala, okuzoba nomthelela omkhulu ekuxilongweni nasekwelashweni, ezindlekweni zokulawula umshwalense wezokwelapha, njll. ukusetshenziswa kwemithi ethile enenani eliphezulu, ngisho nemithi yocwaningo lwangempela, izinkampani ezifanele zemithi zizolimala kakhulu uma zingaguquki ngesikhathi.

Nokho, nakuba ezinye izidakamizwa nezinkampani zizophonselwa inselelo enkulu.Kodwa-ke, imboni ibikezela ukuthi izinhlobonhlobo zezidakamizwa ezinezimfanelo zokusetshenziswa okuqinile, izidakamizwa eziphuthumayo, ukwelashwa kwesigaba sokugcina kanye nezidakamizwa zangaphandle zingase zingathinteki, futhi ngaphansi kokuhlolwa kwezindleko zenzuzo, izokhuthaza ukukhuphuka kwezinga lokungena kwe-ICL kanye nokungenisa. esikhundleni semboni ye-IVD.Ukwengeza, izinsiza ezibalulekile ezikhuphukayo (izinto zokusetshenziswa nemishini, ama-API anelungelo lobunikazi) nazo zingazuza kulokhu.Kunconywa ukuthi unake: WuXi Biologics, Tofflon, Kailai Ying nezinye izinkampani.

三.Inkambu ephumelela kakhulu ye-R&D yokukhishwa kwezidakamizwa

Ngaphansi kwethonya lezici ezinjengokwanda okuphelele kokutshalwa kwezimali kwe-R&D kwezemithi emhlabeni wonke kanye nezinqubomgomo zasekhaya ezivuna ukwenzeka, kuwukuvumelana embonini ukuthi imakethe yesevisi yokukhipha izidakamizwa ye-R&D (okungukuthi, i-CXO), okuyingxenye ebalulekile yochungechunge lwezimboni zezidakamizwa, izoba nomthelela omubi. ngokusobala inzuzo.

Abangaphakathi embonini bakholelwa ukuthi abaqalayo manje sebeba amandla amakhulu ocwaningweni nasekuthuthukisweni kwemithi emisha embonini yezokwelashwa.Kodwa-ke, ngenxa yokushoda kwamathalente, uxhaso, kanye nesikhala, abaqalayo bavame ukwenza lula abasebenzi futhi baphishekele ukusebenza kahle okuphezulu kanye nezindleko eziphansi.Ngakho-ke, bancike ezinkampanini ze-CXO.Ivame ukuba phezulu.Kuyaqondakala ukuthi inkampani esohlwini lwe-CMO ithe ngenxa yalezi zizathu ezingenhla, ingxenye yezinkampani zezidakamizwa eziqalwa yi-bio-innovative ekusebenzeni kwezinkampani ze-CXO iye yanda kancane kancane eminyakeni yamuva, futhi iba umthombo obalulekile womnikelo. ekukhuleni kwemali engenayo nenzuzo yenkampani ye-CXO.


Isikhathi sokuthumela: May-13-2021